Detail akcie Integr Pharm online

Business Summary: Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.
Financial Summary: BRIEF: For the six months ended 30 June 2008, Integrated Pharmaceuticals Inc revenues decreased from $8K to $0K. Net loss decreased 13% to $829K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Legal and professional fees decrease of 56% to $77K (expense), Labor and benefits decrease of 45% to $54K (expense), Consulting decrease of 56% to $26K (expense).